Loading organizations...
Loading organizations...
Biomedical software for advanced cancer patient analysis and therapy.
BostonGene has raised $200.0M across 2 funding rounds.
BostonGene has raised $200.0M in total across 2 funding rounds.
BostonGene has raised $200.0M in total across 2 funding rounds.
BostonGene's investors include Takayuki Morita, Impact Investment Capital, Japan Industrial Partners, Osamu Fujikawa.
BostonGene has raised $200.0M across 2 funding rounds. Most recently, it raised $150.0M Series B in April 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 6, 2022 | $150.0M Series B | Takayuki Morita | Impact Investment Capital, Japan Industrial Partners |
| Apr 25, 2019 | $50.0M Series A | Osamu Fujikawa |